Galenica acquires an 80% stake in Puravita AG to enhance its online pharmacy offerings and broaden its market presence in the growing digital health sector.

Information on the Target

Galenica has announced the acquisition of a majority stake in Puravita AG, increasing its ownership from 34% to 80% as of January 2026. This strategic move positions Galenica as the majority shareholder, enhancing its capability to diversify its business while effectively integrating its online and physical offerings. Puravita, known for its strong customer focus and substantial market presence, is distinguished by its extensive product range and expertise in online sales.

Established in 2016, Puravita AG operates from Speicher (AR) and has become a key player in the online pharmacy sector. The company boasts one of the largest assortments of pharmacy, drugstore, and health food products in Switzerland, with over 45,000 items available online. Under the continued leadership of its founder, Michael Sonderegger, Puravita employs 48 staff and achieves net sales of approximately CHF 22 million.

Industry Overview in Switzerland

The Swiss pharmaceutical and health market is rapidly evolving, primarily driven by the increasing preference for online shopping and the growing demand for health-related products. With a comp